EFFICACY AND SAFETY OF IMAGING-GUIDED TRANSTHORACIC NEEDLE LUNG BIOPSY – A REAL-LIFE STUDY

Authors

  • Claudia Lucia TOMA “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • C.A. PINTILIE “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • Ionela Nicoleta BELACONI “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • G. A. CHIRITA “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • A. EDDAN VISAN “Marius Nasta” Institute of Pneumology, Bucharest, Romania
  • V. S. BACIOIU “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • Stefania Florina OPREA “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • Cristina BIGHIU “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • Paula SILAGHI “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • D. MUSETESCU “Marius Nasta” Institute of Pneumology, Bucharest, Romania
  • R. MATACHE “Marius Nasta” Institute of Pneumology, Bucharest, Romania
  • Milena Adina MAN “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania
  • S. DUMITRACHE-RUJINSKI “Carol Davila” University of Medicine and Pharmacy, Bucharest

DOI:

https://doi.org/10.22551/2qd6a018

Abstract

Despite global efforts, the challenge of early-stage diagnosis of lung cancer persists. To improve diagnose of peripheral lung tumors, a less invasive, cost-effective, and time-efficient sampling technique is essential. Percutaneous imaging-guided transthoracic lung biopsy meets these criteria. Aims: This study aims to determine the efficacy of imaging-guided transthoracic needle lung biopsy and to identify periprocedural complications and diagnostic success rate in a tertiary pulmonology center. Materials and methods: We conducted in “Marius Nasta” Institute of Pulmonology, from Bucharest, Romania, a retrospective, observational study on consecutive patients diagnosed with lung, pleural or chest wall tumors that underwent transthoracic Computed-Tomography (CT)-scan guided needle biopsy or ultrasound (US)-guided needle biopsy. The efficacy and safety of these procedures were assessed. Results: We enrolled 280 patients, with 261 undergoing CT-scan transthoracic guided percutaneous needle biopsy and 19 undergoing US-guided needle biopsy, between 2021 and 2023. Histopathological results were obtained in 267 cases (95.35%) of lung biopsies, with only 13 (4.64%) inconclusive specimens. The reports identified 225 (80.35%) malignant tumors and 42 (15%) other diseases. Out of 225 malignant tumors, 193 (85.77%) were NSCLC. Out of NSCLC 103 were lung adenocarcinomas (53.36%). Periprocedural complications rate was 23.22%, mainly pneumo-thorax, hemoptysis and alveolar hemorrhage. No fatal outcome was recorded. Conclusions: The study underscores the efficacy of percutaneous CT-guided or US-guided transthoracic needle lung biopsy in clinical practice, with an affordable risk of complications. The implication of a multidisciplinary team is essential for the best outcome.

Author Biographies

  • Claudia Lucia TOMA, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

  • C.A. PINTILIE, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department

  • Ionela Nicoleta BELACONI, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

  • G. A. CHIRITA, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology

  • A. EDDAN VISAN, “Marius Nasta” Institute of Pneumology, Bucharest, Romania

    Pneumology 4th Department 

  • V. S. BACIOIU, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

  • Stefania Florina OPREA, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

  • Cristina BIGHIU, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

  • Paula SILAGHI, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

  • D. MUSETESCU, “Marius Nasta” Institute of Pneumology, Bucharest, Romania

    Radiology Department

  • R. MATACHE, “Marius Nasta” Institute of Pneumology, Bucharest, Romania

    Radiology Department

  • S. DUMITRACHE-RUJINSKI, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Discipline of Pneumology
    “Marius Nasta” Institute of Pneumology, Bucharest, Romania
    Pneumology 4th Department 

References

1. European Cancer Information System- https: //ecis.jrc.ec.europa.eu, accessed 15.02.2024.

2. Yamamoto N, Watanabe T, Yamada K, et al. Efficacy and safety of ultrasound (US) guided percuta-neous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy. J Thorac Dis 2019; 11(3): 936-943 / doi: 10.21037/ jtd.2019.01.88.

3. Klein JS, Schultz S, Heffner JE. Interventional radiology of the chest: image-guided percutaneous drainage of pleural effusions, lung abscess, and pneumothorax. AJR Am J Roentgenol 1995; 164(3): 581-588 / doi: 10.2214/ajr.164.3.7863875.

4. Borelli C, Vergara D, Simeone A, Pazienza L, et al. CT-Guided Transthoracic Biopsy of Pulmonary Lesions: Diagnostic versus Nondiagnostic Results. Diagnostics (Basel) 2022; 12(2): 359 / doi: 10.3390/ diagnostics12020359.

5. Tongbai T, McDermott S, Kiranantawat N, et al. Non-Diagnostic CT-Guided Percutaneous Needle Biopsy of the Lung: Predictive Factors and Final Diagnoses. Korean J Radiol 2019; 20(11): 1515-1526 / doi: 10.3348/kjr.2019.0014.

6. Tipaldi MA, Ronconi E, Krokidis ME, et al. Diagnostic yield of CT-guided lung biopsies: how can we limit negative sampling? Br J Radiol 2022; 95(1130): 20210434 / doi: 10.1259/bjr.20 210434.

7. Yang W, Sun W, Li Q, et al. Diagnostic Accuracy of CT-Guided Transthoracic Needle Biopsy for Solitary Pulmonary Nodules. PLoS One 2015; 10(6): e0131373 / doi: 10.1371/journal.pone. 0131373.

8. Xu C, Yuan Q, Chi C, Zhang Q, Wang Y, Wang W, Yu L, Zhan P, Lin Y. Computed tomography-guided percutaneous transthoracic needle biopsy for solitary pulmonary nodules in diameter less than 20 mm. Medicine (Baltimore). 2018; 97(14): e0154 / doi: 10.1097/MD.000000000 0010154.

9. Birchard KR. Transthoracic needle biopsy. Semin Intervent Radiol 2011; 28(1): 87-97 / doi: 10.1055/ s-0031-1273943.

10. Jaconi M, Pagni F, Vacirca F, et al. C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool: an observational study. Medicine (Baltimore) 2015; 94(12): e698 / doi: 10.1097/MD.0000000000000698.

11. Min Zheng, Classification and Pathology of Lung Cancer, Surgical Oncology. Clinics of North America 2016; 25(3): 447-468 / doi: 10.1016/j.soc.2016.02.003.

12. Vachani A, Zhou M, Ghosh S, et al. Complications After Transthoracic Needle Biopsy of Pulmonary Nodules: A Population-Level Retrospective Cohort Analysis. J Am Coll Radiol 2022; 19(10): 1121-1129 / doi: 10.1016/j.jacr.2022.04.010.

13. Huo YR, Chan MV, Habib AR, Lui I, Ridley L. Pneumothorax rates in CT-Guided lung biopsies: a comprehensive systematic review and meta-analysis of risk factors. Br J Radiol 2020; 93(1108): 20190866 / doi: 10.1259/bjr.20190866.

14. Choi CM, Um SW, Yoo CG, et al. Incidence and risk factors of delayed pneumothorax after transtho-racic needle biopsy of the lung. Chest 2004; 126(5): 1516-1521 / doi: 10.1378/chest.126. 5.1516.

Additional Files

Published

2025-04-07